Containment Level 3 (CL3) for Tuberculosis Research
The RI has a 535 m2 CL3 (also known as Biosafety Level 3 or BSL3) Facility for TB research that meets the highest safety standards as defined by Canadian guidelines (PHAC and others) under the direction of Dr. Marcel Behr.
Work carried out in this Facility includes all experimental procedures where there is manipulation of live Mycobacterium tuberculosis. The Facility is available to RI researchers, affiliated researchers/collaborators and external researchers working on tuberculosis.
All work to be carried out in the CL3 Lab must follow the established SOPs, as defined in the Facility's SOP manual. The CL3 Facility comprises one room for bacterial manipulation and an adjoining room for experiments.
Once a set of investigations is approved, the facility manager will oversee training and provide both guidance to researchers and monitoring of experiments.

For further information on the RI MUHC CL3, please contact Fiona McIntosh, Facility manager, at:
Research Institute of the McGill University Health Centre
1650 Cedar Avenue, Room RS1-111
Montreal, Quebec H3G 1A4
phone: 514-934-1934 Ext. 44619 fax: 514-934-8261
fiona.mcintosh@gmail.com